Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Defective phenotype of mesenchymal stem cells in patients with systemic lupus erythematosus.

Lupus - 1 Jun 2010

Nie Y, Lau Cs, Lie Akw, Chan Gcf, Mok My

Abstract excerpt

Systemic lupus erythematosus (SLE) has been considered as stem cell disorder. The objective of this study was to examine the phenotype, growth and immunomodulatory effect of mesenchymal stem cells (MSCs) from SLE patients compared with those from age- and sex-matched healthy donors. MSCs were expanded from bone marrow aspirate and were examined for morphological appearance, quantified in different passages to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 5'-Nucleotidase
Share to Cellular Senescence
Share to Endoglin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lupus Erythematosus, Systemic

Share to Mesenchymal Stem Cells

Share to Receptors, Cell Surface

Share to Telomerase

Share to Thy-1 Antigens

Source

Identifiers

PMID: 20511276
DOI: 10.1177/0961203309361482

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Defective phenotype of mesenchymal stem cells in patients with systemic lupus erythematosus.PMID 20511276Read ↗

Defective phenotype of mesenchymal stem cells in patients with systemic lupus erythematosusSemantic proximity Read ↗

Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus.Semantic proximity Read ↗

Gene Expression Profile Reveals Abnormalities of Multiple Signaling Pathways in Mesenchymal Stem Cell Derived from Patients with Systemic Lupus ErythematosusSemantic proximity Read ↗

Investigating the Role of IL-6 in the Pathogenesis of Systemic Lupus Erythematosus: Insights from Bone Marrow Mesenchymal Stem CellsSemantic proximity Read ↗

Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosusSemantic proximity Read ↗

Bone Marrow-Derived Mesenchymal Stem Cells From Patients With Systemic Lupus Erythematosus Have a Senescence-Associated Secretory Phenotype Mediated by a Mitochondrial Antiviral Signaling Protein-Interferon-β Feedback Loop.Semantic proximity Read ↗

Overexpression of SOX4 in MSCs inhibits cellular senescence and enhances therapeutic efficacy in systemic lupus erythematosusSemantic proximity Read ↗

Circulating Exosomes Derived-miR-146a from Systemic Lupus Erythematosus Patients Regulates Senescence of Mesenchymal Stem CellsSemantic proximity Read ↗

Abnormal differentiation of memory T cells in systemic lupus erythematosus.Semantic proximity Read ↗

The Phenotype and Secretory Activity of Adipose-Derived Mesenchymal Stem Cells (ASCs) of Patients with Rheumatic Diseases.Semantic proximity Read ↗

Phenotypic and functional abnormalities of bone marrow-derived dendritic cells in systemic lupus erythematosus.Semantic proximity Read ↗

MSC Transplantation Improves Osteopenia via Epigenetic Regulation of Notch Signaling in LupusSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.